Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "launches study African American cancer survivors" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about launches study African American cancer survivors for you to read. Along with our medical data and news we also list launches study African American cancer survivors Clinical Trials, which are updated daily. BioPortfolio also has a large database of launches study African American cancer survivors Companies for you to search.
The National Cancer Institute in Vilnius and the University Clinic of Kaunas are now ready to start inclusion of patients in Part II of the LPC-004 study. Lithuanian authorities have recently approved the study protocol and the Liproca® Depot injection kits are already on site. In order to further improve the inclusion rate in Part II of the Phase IIb study, LIDDS has signed agreements ...
Use of low-dose aspirin is associated with a reduced risk of ovarian cancer, results from a cohort study show.
Cancer cases in Hong Kong projected to rise by up to 40% by 2030 https://sc.mp/kbypc
Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today that management will present a company update at the 30th Annual Piper Jaffray Healthcare Conference. The presentation will take place at 8:10 a.m. ET on Tuesday, November 27, 2018. ...
China cracks down on African swine fever reporting https://reut.rs/2QUHqsm
China cracks down on obstruction of African swine fever reporting https://reut.rs/2DMyBxO
SummaryImmunocore Ltd Immunocore is a biotechnology company that focuses on the development of immunotherapeutic drugs for the treatment of cancer, infectious diseases and autoimmune diseases. The company develops its drugs using its proprietary T cell receptor TCR technology. Its products under development include IMCgp100, an ImmTAC reagent used to treat patients with advanced cutaneous and uvea...
xB3-001 demonstrated lymphatic system penetration and more selective tissue distribution with xB3-001 than trastuzumab alone The Company has filed patent applications based on these observations and those data may have broader applicability An updated version of the corporate presentation is available for review at
SummaryAxelar AB Axelar is a drug development company that develops various novel anticancer treatments. The company lead drug candidateAXL1717 is used for the treatmentof nonsmall cell lung cancer. It also offers treatments for disease such as glioblastoma, sarcoma, malignant melanoma and multiple myeloma, and others. Axelar conducts research on inhibitors of insulinlike growth factor1 receptor a...
WARSAW, Poland, Nov. 20, 2018 /PRNewswire/ -- Trinus has just launched their new, innovate three-in-one transformable travel bag. The Trinus 3-in-1 has a unique folding Read more...
LOS ANGELES, Nov. 20, 2018 /PRNewswire/ -- With many families affected by wildfires unable to spend the Thanksgiving holiday at home, the American Red Cross Read more...
China on Wednesday issued new rules to tighten notification of cases of African swine fever, including incentives for whistleblowers, amid concerns that outbreaks of the highly contagious disease are being under reported.
SummaryImmatics Biotechnologies GmbH Immatics is a clinical stage biopharmaceutical company that develops drugs for the treatment of cancer. It develops peptide based active immunotherapy drug candidates based on it novel technology, XPRESIDENT discovery platform. The company has active programs in several tumor types including gastric cancer, nonsmallcell lung cancer and prostate cancer. Its majo...
Misconceptions about the use of strong opioids showed to undermine optimal pain control among Asian cancer patients undergoing chemotherapy and radiotherapy according to a cross-sectional survey conducted at the Sarawak General Hospital in Malaysia.
The Phase III study protocol is modified after IBT’s meeting with the FDA Yesterday afternoon (EST) Infant Bacterial Therapeutics had a meeting with the US Food and Drug Administration (FDA) in Washington DC to discuss the design of the company's clinical development program. As a consequence of these discussions, IBT has chosen to modify its Phase III study for the prevention of necrotizing ...
Researchers from Newcastle University (UK) are investigating the genetic causes of male infertility — an often-overlooked condition about which very little is known. With a NovaSeq sequencing system from Illumina at their disposal, plus 1500 study participants suffering from infertility, the researchers hope to better understand some of the underlying genetic factors behind this condition. “T...
Even with the Thanksgiving week, there is interesting and exciting research being conducted and published. Here’s a look.
(Wiley) In a Geriatrics & Gerontology International study of 51 individuals living with dementia who attended community-based adult day health centers, behavioral observations of a music intervention showed a positive change in mood and a decrease in agitation.
(Wiley) Men who use androgenic anabolic steroids -- such as testosterone -- may face a higher risk of early death and of experiencing more hospital admissions, according to a new Journal of Internal Medicine study.
(Wiley) In a Journal of the American Geriatrics Society study of adults aged 65 and older who were functionally independent, individuals with cardiovascular disease (CVD) were more likely to experience rapid functional decline than those without.
(Wiley) Compared with women in a recent study who slept seven to eight hours each night, women who slept for five hours or 10 hours had about a 25 percent increased odds of experiencing recurrent falls (falling at least twice in a year).
(Wiley) British children with intellectual disabilities are more likely than their peers to live in areas with high outdoor air pollution, according to a new Journal of Intellectual Disability Research study funded by Public Health England.
(Wiley) A recent analysis of data related to the brown bear (Ursus arctos) estimates that suitable habitat will be reduced by 11 percent across Central Asia and the Asian Highlands by 2050 due to climate change, predominantly due to the changes in temperature and precipitation. The findings are published in Ecology and Evolution.
A new cellular immunotherapy treatment that targets the Epstein-Barr virus (EBV) has been found to improve multiple sclerosis (MS) symptoms. The treatment is developed by Professor Rajiv Khanna and his team at QIMR Berghofer Medical Research Institute. It is based on the theory of Professor Michael Pender, from The University of Queensland and the Royal Brisbane and Women’s Hospital (RBWH), th...
The platforms aim to assist in the diagnosis and treatment of breast cancer and heart disease BEIJING, Nov. 20, 2018 /PRNewswire/ -- Huiyihuiying (HY), a Chinese medical imaging artificial intelligence company, launched its new platform, the AI Full Cycle Health Management Cloud Platform, which consists of two separate platforms for different health concerns:...